CoChat

mTORC1 pathway in DNA damage response

Open access
Ma, Yinxing, Vassetzky, Yegor, Dokudovskaya, Svetlana · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Cited by 154

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Abstract

Living organisms have evolved various mechanisms to control their metabolism and response to various stresses, allowing them to survive and grow in different environments. In eukaryotes, the highly conserved mechanistic target of rapamycin (mTOR) signaling pathway integrates both intracellular and extracellular signals and serves as a central regulator of cellular metabolism, proliferation and survival. A growing body of evidence indicates that mTOR signaling is closely related to another cellular protection mechanism, the DNA damage response (DDR). Many factors important for the DDR are also involved in the mTOR pathway. In this review, we discuss how these two pathways communicate to ensure an efficient protection of the cell against metabolic and genotoxic stresses. We also describe how anticancer therapies benefit from simultaneous targeting of the DDR and mTOR pathways.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbamcr.2018.06.011

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 76 references

Research works printed but not linked: 157

  1. Loewith, 2011, Target of rapamycin (TOR) in nutrient signaling and growth control, Genetics, 189, 1177, 10.1534/genetics.111.133363 · DOI · Paper page
  2. Sabatini, 1994, RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs, Cell, 78, 35, 10.1016/0092-8674(94)90570-3 · DOI · Paper page
  3. Betz, 2013, Where is mTOR and what is it doing there?, J. Cell Biol., 203, 563, 10.1083/jcb.201306041 · DOI · Paper page
  4. Gingras, 1999, Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism, Genes Dev., 13, 1422, 10.1101/gad.13.11.1422 · DOI · Paper page
  5. Poulin, 1998, 4E-BP3, a new member of the eukaryotic initiation factor 4E-binding protein family, J. Biol. Chem., 273, 14002, 10.1074/jbc.273.22.14002 · DOI · Paper page
  6. Robitaille, 2013, Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis, Science, 339, 1320, 10.1126/science.1228771 · DOI · Paper page
  7. Porstmann, 2008, SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth, Cell Metab., 8, 224, 10.1016/j.cmet.2008.07.007 · DOI · Paper page
  8. Peterson, 2011, mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway, Cell, 146, 408, 10.1016/j.cell.2011.06.034 · DOI · Paper page
  9. Rousseau, 2016, An evolutionarily conserved pathway controls proteasome homeostasis, Nature, 536, 184, 10.1038/nature18943 · DOI · Paper page
  10. Zhao, 2015, mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy, Proc. Natl. Acad. Sci. U. S. A., 112, 15790, 10.1073/pnas.1521919112 · DOI · Paper page
  11. Zhao, 2016, Coordinate regulation of autophagy and the ubiquitin proteasome system by MTOR, Autophagy, 12, 1967, 10.1080/15548627.2016.1205770 · DOI
  12. Yin, 2016, Autophagy: machinery and regulation, Microb. Cell, 3, 588, 10.15698/mic2016.12.546 · DOI · Paper page
  13. Saxton, 2016, Mechanism of arginine sensing by CASTOR1 upstream of mTORC1, Nature, 536, 229, 10.1038/nature19079 · DOI · Paper page
  14. Wang, 2015, Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1, Science, 347, 188, 10.1126/science.1257132 · DOI · Paper page
  15. Wyant, 2017, mTORC1 activator SLC38A9 is required to efflux essential amino acids from lysosomes and use protein as a nutrient, Cell, 171, 642, 10.1016/j.cell.2017.09.046 · DOI · Paper page
  16. Gu, 2017, SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway, Science, 358, 813, 10.1126/science.aao3265 · DOI · Paper page
  17. Wolfson, 2017, KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1, Nature, 543, 438, 10.1038/nature21423 · DOI · Paper page
  18. Kim, 2012, SH3BP4 is a negative regulator of amino acid-Rag GTPase-mTORC1 signaling, Mol. Cell, 46, 833, 10.1016/j.molcel.2012.04.007 · DOI · Paper page
  19. Peng, 2014, Sestrins function as guanine nucleotide dissociation inhibitors for Rag GTPases to control mTORC1 signaling, Cell, 159, 122, 10.1016/j.cell.2014.08.038 · DOI · Paper page
  20. Han, 2012, Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway, Cell, 149, 410, 10.1016/j.cell.2012.02.044 · DOI · Paper page
  21. Villanueva-Paz, 2016, AMPK regulation of cell growth, apoptosis, autophagy, and bioenergetics, EXS, 107, 45
  22. Parmigiani, 2016, Sensing the environment through sestrins: implications for cellular metabolism, Int. Rev. Cell Mol. Biol., 327, 1, 10.1016/bs.ircmb.2016.05.003 · DOI
  23. Eker, 2009, DNA repair in mammalian cells: direct DNA damage reversal: elegant solutions for nasty problems, Cell. Mol. Life Sci., 66, 968, 10.1007/s00018-009-8735-0 · DOI
  24. Reyes, 2015, New insights into the mechanism of DNA mismatch repair, Chromosoma, 124, 443, 10.1007/s00412-015-0514-0 · DOI
  25. Whitaker, 2017, Base excision repair of oxidative DNA damage: from mechanism to disease, Front. Biosci., 22, 1493, 10.2741/4555 · DOI · Paper page
  26. Scharer, 2013, Nucleotide excision repair in eukaryotes, Cold Spring Harb. Perspect. Biol., 5, a012609, 10.1101/cshperspect.a012609 · DOI · Paper page
  27. Chapman, 2012, Playing the end game: DNA double-strand break repair pathway choice, Mol. Cell, 47, 497, 10.1016/j.molcel.2012.07.029 · DOI · Paper page
  28. Bhargava, 2016, Regulation of single-strand annealing and its role in genome maintenance, Trends Genet., 32, 566, 10.1016/j.tig.2016.06.007 · DOI · Paper page
  29. Rodriguez-Vargas, 2012, ROS-induced DNA damage and PARP-1 are required for optimal induction of starvation-induced autophagy, Cell Res., 22, 1181, 10.1038/cr.2012.70 · DOI · Paper page
  30. Munoz-Gamez, 2009, PARP-1 is involved in autophagy induced by DNA damage, Autophagy, 5, 61, 10.4161/auto.5.1.7272 · DOI · Paper page
  31. Paull, 2015, Mechanisms of ATM activation, Annu. Rev. Biochem., 84, 711, 10.1146/annurev-biochem-060614-034335 · DOI · Paper page
  32. Alexander, 2010, ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS, Proc. Natl. Acad. Sci. U. S. A., 107, 4153, 10.1073/pnas.0913860107 · DOI · Paper page
  33. Zhang, 2015, ATM functions at the peroxisome to induce pexophagy in response to ROS, Nat. Cell Biol., 17, 1259, 10.1038/ncb3230 · DOI · Paper page
  34. Kim, 2002, Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage, Genes Dev., 16, 560, 10.1101/gad.970602 · DOI · Paper page
  35. Tsai, 2008, Functional interaction between FOXO3a and ATM regulates DNA damage response, Nat. Cell Biol., 10, 460, 10.1038/ncb1709 · DOI · Paper page
  36. Zhao, 2011, AMPK-dependent phosphorylation of ULK1 induces autophagy, Cell Metab., 13, 119, 10.1016/j.cmet.2011.01.009 · DOI · Paper page
  37. Selvarajah, 2015, DNA damage-induced S and G2/M cell cycle arrest requires mTORC2-dependent regulation of Chk1, Oncotarget, 6, 427, 10.18632/oncotarget.2813 · DOI
  38. Ma, 2017, Tumor suppressor NPRL2 induces ROS production and DNA damage response, Sci. Rep., 7, 15311, 10.1038/s41598-017-15497-0 · DOI
  39. Shen, 2013, The mTOR pathway negatively controls ATM by up-regulating miRNAs, Proc. Natl. Acad. Sci. U. S. A., 110, 11869, 10.1073/pnas.1220898110 · DOI · Paper page
  40. Zhou, 2017, Regulation of CHK1 by mTOR contributes to the evasion of DNA damage barrier of cancer cells, Sci. Rep., 7, 1535, 10.1038/s41598-017-01729-w · DOI
  41. Xie, 2018, The mTOR-S6K pathway links growth signalling to DNA damage response by targeting RNF168, Nat. Cell Biol., 20, 320, 10.1038/s41556-017-0033-8 · DOI · Paper page
  42. Li, 2013, Protein phosphatase 2A and DNA-dependent protein kinase are involved in mediating rapamycin-induced Akt phosphorylation, J. Biol. Chem., 288, 13215, 10.1074/jbc.M113.463679 · DOI
  43. Dey, 2015, High glucose enhances microRNA-26a to activate mTORC1 for mesangial cell hypertrophy and matrix protein expression, Cell. Signal., 27, 1276, 10.1016/j.cellsig.2015.03.007 · DOI
  44. Franke, 1997, Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate, Science, 275, 665, 10.1126/science.275.5300.665 · DOI · Paper page
  45. Alessi, 1996, Mechanism of activation of protein kinase B by insulin and IGF-1, EMBO J., 15, 6541, 10.1002/j.1460-2075.1996.tb01045.x · DOI · Paper page
  46. Xu, 2012, Akt: a double-edged sword in cell proliferation and genome stability, J. Oncol., 2012, 951724, 10.1155/2012/951724 · DOI · Paper page
  47. Kovacina, 2003, Identification of a proline-rich Akt substrate as a 14-3-3 binding partner, J. Biol. Chem., 278, 10189, 10.1074/jbc.M210837200 · DOI · Paper page
  48. Thedieck, 2007, PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis, PLoS One, 2, e1217, 10.1371/journal.pone.0001217 · DOI · Paper page
  49. Vander Haar, 2007, Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40, Nat. Cell Biol., 9, 316, 10.1038/ncb1547 · DOI · Paper page
  50. Yu, 2011, Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling, Science, 332, 1322, 10.1126/science.1199484 · DOI · Paper page
  51. Leslie, 2004, PTEN function: how normal cells control it and tumour cells lose it, Biochem. J., 382, 1, 10.1042/BJ20040825 · DOI · Paper page
  52. Viniegra, 2005, Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM, J. Biol. Chem., 280, 4029, 10.1074/jbc.M410344200 · DOI · Paper page
  53. Caporali, 2008, AKT is activated in an ataxia-telangiectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition, Mol. Pharmacol., 74, 173, 10.1124/mol.107.044743 · DOI
  54. Bozulic, 2008, PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival, Mol. Cell, 30, 203, 10.1016/j.molcel.2008.02.024 · DOI · Paper page
  55. Kandel, 2002, Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage, Mol. Cell. Biol., 22, 7831, 10.1128/MCB.22.22.7831-7841.2002 · DOI · Paper page
  56. Toulany, 2006, Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair, Clin. Cancer Res., 12, 4119, 10.1158/1078-0432.CCR-05-2454 · DOI · Paper page
  57. Kao, 2007, Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation, J. Biol. Chem., 282, 21206, 10.1074/jbc.M703042200 · DOI · Paper page
  58. Toulany, 2008, Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair, Mol. Cancer Ther., 7, 1772, 10.1158/1535-7163.MCT-07-2200 · DOI · Paper page
  59. Toulany, 2012, Akt promotes post-irradiation survival of human tumor cells through initiation, progression, and termination of DNA-PKcs-dependent DNA double-strand break repair, Mol. Cancer Res., 10, 945, 10.1158/1541-7786.MCR-11-0592 · DOI · Paper page
  60. Holler, 2016, Dual targeting of Akt and mTORC1 impairs repair of DNA double-strand breaks and increases radiation sensitivity of human tumor cells, PLoS One, 11, e0154745, 10.1371/journal.pone.0154745 · DOI
  61. Cam, 2014, p53/TAp63 and AKT regulate mammalian target of rapamycin complex 1 (mTORC1) signaling through two independent parallel pathways in the presence of DNA damage, J. Biol. Chem., 289, 4083, 10.1074/jbc.M113.530303 · DOI · Paper page
  62. Piscitello, 2017, AKT overactivation can suppress DNA repair via p70S6 kinase-dependent downregulation of MRE11, Oncogene, 37, 427, 10.1038/onc.2017.340 · DOI
  63. Workman, 2014, Environmental signaling through the mechanistic target of rapamycin complex 1: mTORC1 goes nuclear, Cell Cycle, 13, 714, 10.4161/cc.28112 · DOI
  64. Giguere, 2018, Canonical signaling and nuclear activity of mTOR-a teamwork effort to regulate metabolism and cell growth, FEBS J., 285, 1572, 10.1111/febs.14384 · DOI
  65. Vega-Rubin-de-Celis, 2017, Multistep regulation of TFEB by MTORC1, Autophagy, 13, 464, 10.1080/15548627.2016.1271514 · DOI · Paper page
  66. Bertram, 2000, Tripartite regulation of Gln3p by TOR, Ure2p, and phosphatases, J. Biol. Chem., 275, 35727, 10.1074/jbc.M004235200 · DOI · Paper page
  67. Roczniak-Ferguson, 2012, The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis, Sci. Signal., 5, ra42, 10.1126/scisignal.2002790 · DOI · Paper page
  68. Settembre, 2012, A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB, EMBO J., 31, 1095, 10.1038/emboj.2012.32 · DOI · Paper page
  69. Matsushita, 2011, Direct inhibition of TNF-alpha promoter activity by Fanconi anemia protein FANCD2, PLoS One, 6, e23324, 10.1371/journal.pone.0023324 · DOI
  70. Palovcak, 2017, Maintenance of genome stability by Fanconi anemia proteins, Cell Biosci., 7, 8, 10.1186/s13578-016-0134-2 · DOI
  71. Guo, 2013, mTOR regulates DNA damage response through NF-kappaB-mediated FANCD2 pathway in hematopoietic cells, Leukemia, 27, 2040, 10.1038/leu.2013.93 · DOI
  72. Shen, 2013, Regulation of FANCD2 by the mTOR pathway contributes to the resistance of cancer cells to DNA double-strand breaks, Cancer Res., 73, 3393, 10.1158/0008-5472.CAN-12-4282 · DOI
  73. Chaveroux, 2013, Molecular and genetic crosstalks between mTOR and ERRalpha are key determinants of rapamycin-induced nonalcoholic fatty liver, Cell Metab., 17, 586, 10.1016/j.cmet.2013.03.003 · DOI
  74. Audet-Walsh, 2017, Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer, Genes Dev., 31, 1228, 10.1101/gad.299958.117 · DOI
  75. Vazquez-Martin, 2011, Raptor, a positive regulatory subunit of mTOR complex 1, is a novel phosphoprotein of the rDNA transcription machinery in nucleoli and chromosomal nucleolus organizer regions (NORs), Cell Cycle, 10, 3140, 10.4161/cc.10.18.17376 · DOI
  76. Yadav, 2013, mTOR direct interactions with Rheb-GTPase and raptor: sub-cellular localization using fluorescence lifetime imaging, BMC Cell Biol., 14, 3, 10.1186/1471-2121-14-3 · DOI · Paper page
  77. Grove, 2017, Control of RNA polymerase II-transcribed genes by direct binding of TOR kinase, Curr. Genet., 64, 131, 10.1007/s00294-017-0738-z · DOI
  78. Panday, 2017, DNA damage regulates direct association of TOR kinase with the RNA polymerase II-transcribed HMO1 gene, Mol. Biol. Cell, 28, 2449, 10.1091/mbc.e17-01-0024 · DOI
  79. Kasahara, 2011, Hmo1 directs pre-initiation complex assembly to an appropriate site on its target gene promoters by masking a nucleosome-free region, Nucleic Acids Res., 39, 4136, 10.1093/nar/gkq1334 · DOI
  80. Panday, 2015, Yeast high mobility group protein HMO1 stabilizes chromatin and is evicted during repair of DNA double strand breaks, Nucleic Acids Res., 43, 5759, 10.1093/nar/gkv498 · DOI
  81. Whitney, 2009, ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression, Biochem. Biophys. Res. Commun., 379, 451, 10.1016/j.bbrc.2008.12.079 · DOI · Paper page
  82. Qiao, 2015, A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacity, Nat. Commun., 6, 7014, 10.1038/ncomms8014 · DOI · Paper page
  83. Regazzetti, 2012, Regulated in development and DNA damage responses −1 (REDD1) protein contributes to insulin signaling pathway in adipocytes, PLoS One, 7, e52154, 10.1371/journal.pone.0052154 · DOI
  84. Dungan, 2017, Regulation of skeletal muscle insulin-stimulated signaling through the MEK-REDD1-mTOR axis, Biochem. Biophys. Res. Commun., 482, 1067, 10.1016/j.bbrc.2016.11.159 · DOI
  85. Dennis, 2013, Regulated in DNA damage and development 1 (REDD1) promotes cell survival during serum deprivation by sustaining repression of signaling through the mechanistic target of rapamycin in complex 1 (mTORC1), Cell. Signal., 25, 2709, 10.1016/j.cellsig.2013.08.038 · DOI
  86. Pastor, 2017, Implication of REDD1 in the activation of inflammatory pathways, Sci. Rep., 7, 7023, 10.1038/s41598-017-07182-z · DOI
  87. Horak, 2010, Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis, Proc. Natl. Acad. Sci. U. S. A., 107, 4675, 10.1073/pnas.0907705107 · DOI · Paper page
  88. Czarny, 2015, Autophagy in DNA damage response, Int. J. Mol. Sci., 16, 2641, 10.3390/ijms16022641 · DOI · Paper page
  89. Hasty, 2013, mTORC1 and p53: clash of the gods?, Cell Cycle, 12, 20, 10.4161/cc.22912 · DOI · Paper page
  90. Lai, 2010, S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response, EMBO J., 29, 2994, 10.1038/emboj.2010.166 · DOI
  91. Hu, 2012, The regulation of multiple p53 stress responses is mediated through MDM2, Genes Cancer, 3, 199, 10.1177/1947601912454734 · DOI · Paper page
  92. Budanov, 2002, Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability, Oncogene, 21, 6017, 10.1038/sj.onc.1205877 · DOI · Paper page
  93. Feng, 2005, The coordinate regulation of the p53 and mTOR pathways in cells, Proc. Natl. Acad. Sci. U. S. A., 102, 8204, 10.1073/pnas.0502857102 · DOI · Paper page
  94. Zhang, 2003, Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR, J. Clin. Invest., 112, 1223, 10.1172/JCI200317222 · DOI
  95. Shin, 2012, Nrf2-ARE pathway regulates induction of Sestrin-2 expression, Free Radic. Biol. Med., 53, 834, 10.1016/j.freeradbiomed.2012.06.026 · DOI · Paper page
  96. Ye, 2015, GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2, Genes Dev., 29, 2331, 10.1101/gad.269324.115 · DOI · Paper page
  97. Zhang, 2013, Upregulation of sestrin 2 expression via JNK pathway activation contributes to autophagy induction in cancer cells, Cell. Signal., 25, 150, 10.1016/j.cellsig.2012.09.004 · DOI
  98. Sanli, 2012, Sestrin2 modulates AMPK subunit expression and its response to ionizing radiation in breast cancer cells, PLoS One, 7, 10.1371/journal.pone.0032035 · DOI · Paper page
  99. Ben-Sahra, 2013, Sestrin2 integrates Akt and mTOR signaling to protect cells against energetic stress-induced death, Cell Death Differ., 20, 611, 10.1038/cdd.2012.157 · DOI
  100. Zhao, 2014, Sestrin2 protein positively regulates AKT enzyme signaling and survival in human squamous cell carcinoma and melanoma cells, J. Biol. Chem., 289, 35806, 10.1074/jbc.M114.595397 · DOI · Paper page
  101. Dokudovskaya, 2015, SEA you later alli-GATOR - a dynamic regulator of the TORC1 stress response pathway, J. Cell Sci., 128, 2219, 10.1242/jcs.168922 · DOI · Paper page
  102. Li, 2004, Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C, Cancer Res., 64, 6438, 10.1158/0008-5472.CAN-03-3869 · DOI · Paper page
  103. Otani, 2009, The tumor suppressor NPRL2 in hepatocellular carcinoma plays an important role in progression and can be served as an independent prognostic factor, J. Surg. Oncol., 100, 358, 10.1002/jso.21241 · DOI
  104. Ueda, 2006, The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells, Cancer Res., 66, 9682, 10.1158/0008-5472.CAN-06-1483 · DOI
  105. Jayachandran, 2010, NPRL2 sensitizes human non-small cell lung cancer (NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway, PLoS One, 5, e11994, 10.1371/journal.pone.0011994 · DOI
  106. Algret, 2014, Molecular architecture and function of the SEA complex, a modulator of the TORC1 pathway, Mol. Cell. Proteomics, 13, 2855, 10.1074/mcp.M114.039388 · DOI · Paper page
  107. Dokudovskaya, 2011, A conserved coatomer-related complex containing Sec13 and Seh1 dynamically associates with the vacuole in Saccharomyces cerevisiae, Mol. Cell. Proteomics, 10, 006478
  108. Panchaud, 2013, SEACing the GAP that nEGOCiates TORC1 activation: evolutionary conservation of Rag GTPase regulation, Cell Cycle, 12, 1, 10.4161/cc.26000 · DOI · Paper page
  109. Sutter, 2013, Methionine inhibits autophagy and promotes growth by inducing the SAM-responsive methylation of PP2A, Cell, 154, 403, 10.1016/j.cell.2013.06.041 · DOI · Paper page
  110. Tate, 2013, Five conditions commonly used to down regulate TorC1 generate different physiological situations exhibiting distinct requirements and outcomes, J. Biol. Chem., 288, 27243, 10.1074/jbc.M113.484386 · DOI
  111. Hughes Hallett, 2014, State transitions in the TORC1 signaling pathway and information processing in Saccharomyces cerevisiae, Genetics, 198, 773, 10.1534/genetics.114.168369 · DOI · Paper page
  112. Goodarzi, 2004, Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A, EMBO J., 23, 4451, 10.1038/sj.emboj.7600455 · DOI · Paper page
  113. Dozier, 2004, Regulation of Chk2 phosphorylation by interaction with protein phosphatase 2A via its B' regulatory subunit, Biol. Cell, 96, 509, 10.1016/j.biolcel.2004.04.010 · DOI · Paper page
  114. Ferrari, 2017, PP2A controls genome integrity by integrating nutrient-sensing and metabolic pathways with the DNA damage response, Mol. Cell, 67, 266, 10.1016/j.molcel.2017.05.027 · DOI
  115. Turcotte, 2010, Targeting cancer cells through autophagy for anticancer therapy, Curr. Opin. Cell Biol., 22, 246, 10.1016/j.ceb.2009.12.007 · DOI
  116. Dalby, 2010, Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer, Autophagy, 6, 322, 10.4161/auto.6.3.11625 · DOI · Paper page
  117. Gomes, 2017, Autophagy roles in the modulation of DNA repair pathways, Int. J. Mol. Sci., 18, 10.3390/ijms18112351 · DOI
  118. Dunlop, 2014, mTOR and autophagy: a dynamic relationship governed by nutrients and energy, Semin. Cell Dev. Biol., 36, 121, 10.1016/j.semcdb.2014.08.006 · DOI · Paper page
  119. Martina, 2012, MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB, Autophagy, 8, 903, 10.4161/auto.19653 · DOI · Paper page
  120. Morselli, 2011, p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200, Cell Cycle, 10, 2763, 10.4161/cc.10.16.16868 · DOI · Paper page
  121. Maiuri, 2009, Stimulation of autophagy by the p53 target gene Sestrin2, Cell Cycle, 8, 1571, 10.4161/cc.8.10.8498 · DOI · Paper page
  122. Anderson, 1981, Sequence and organization of the human mitochondrial genome, Nature, 290, 457, 10.1038/290457a0 · DOI · Paper page
  123. Saki, 2017, DNA damage related crosstalk between the nucleus and mitochondria, Free Radic. Biol. Med., 107, 216, 10.1016/j.freeradbiomed.2016.11.050 · DOI · Paper page
  124. Alexeyev, 2013, The maintenance of mitochondrial DNA integrity–critical analysis and update, Cold Spring Harb. Perspect. Biol., 5, a012641, 10.1101/cshperspect.a012641 · DOI · Paper page
  125. King, 1989, Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation, Science, 246, 500, 10.1126/science.2814477 · DOI · Paper page
  126. Alexeyev, 2008, Selective elimination of mutant mitochondrial genomes as therapeutic strategy for the treatment of NARP and MILS syndromes, Gene Ther., 15, 516, 10.1038/gt.2008.11 · DOI
  127. Ding, 2010, Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming, J. Biol. Chem., 285, 27879, 10.1074/jbc.M110.119537 · DOI · Paper page
  128. Li, 2010, Multi-mechanisms are involved in reactive oxygen species regulation of mTORC1 signaling, Cell. Signal., 22, 1469, 10.1016/j.cellsig.2010.05.015 · DOI
  129. Yoshida, 2011, Redox regulates mammalian target of rapamycin complex 1 (mTORC1) activity by modulating the TSC1/TSC2-Rheb GTPase pathway, J. Biol. Chem., 286, 32651, 10.1074/jbc.M111.238014 · DOI · Paper page
  130. Tang, 2013, Atg9 interacts with dTRAF2/TRAF6 to regulate oxidative stress-induced JNK activation and autophagy induction, Dev. Cell, 27, 489, 10.1016/j.devcel.2013.10.017 · DOI
  131. Ryter, 2013, Regulation of autophagy in oxygen-dependent cellular stress, Curr. Pharm. Des., 19, 2747, 10.2174/1381612811319150010 · DOI
  132. Kawagishi, 2014, Unraveling the truth about antioxidants: ROS and disease: finding the right balance, Nat. Med., 20, 711, 10.1038/nm.3625 · DOI
  133. Ding, 2016, Sestrin2 is induced by glucose starvation via the unfolded protein response and protects cells from non-canonical necroptotic cell death, Sci. Rep., 6
  134. Kim, 2015, Janus-faced Sestrin2 controls ROS and mTOR signalling through two separate functional domains, Nat. Commun., 6, 10025, 10.1038/ncomms10025 · DOI · Paper page
  135. Rinaldi, 2017, Mitochondrial AKAP1 supports mTOR pathway and tumor growth, Cell Death Dis., 8, e2842, 10.1038/cddis.2017.241 · DOI
  136. Ke, 2018, Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism, Cell Biol. Int., 42, 384, 10.1002/cbin.10915 · DOI · Paper page
  137. Canto, 2011, Calorie restriction: is AMPK a key sensor and effector?, Physiology (Bethesda), 26, 214
  138. Ho, 2013, SIRT4 regulates ATP homeostasis and mediates a retrograde signaling via AMPK, Aging, 5, 835, 10.18632/aging.100616 · DOI · Paper page
  139. Birch, 2017, Targeting the SASP to combat ageing: mitochondria as possible intracellular allies?, Bioessays, 39, 10.1002/bies.201600235 · DOI · Paper page
  140. Liko, 2015, mTOR in health and in sickness, J. Mol. Med., 93, 1061, 10.1007/s00109-015-1326-7 · DOI
  141. Guri, 2016, mTOR signaling confers resistance to targeted cancer drugs, Trends Cancer, 2, 688, 10.1016/j.trecan.2016.10.006 · DOI
  142. Plo, 2008, AKT1 inhibits homologous recombination by inducing cytoplasmic retention of BRCA1 and RAD51, Cancer Res., 68, 9404, 10.1158/0008-5472.CAN-08-0861 · DOI
  143. Beuvink, 2005, The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation, Cell, 120, 747, 10.1016/j.cell.2004.12.040 · DOI · Paper page
  144. Choo, 2008, Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation, Proc. Natl. Acad. Sci. U. S. A., 105, 17414, 10.1073/pnas.0809136105 · DOI · Paper page
  145. Choo, 2009, Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy, Cell Cycle, 8, 567, 10.4161/cc.8.4.7659 · DOI · Paper page
  146. Liu, 2013, Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR, Cancer Res., 73, 2574, 10.1158/0008-5472.CAN-12-1702 · DOI · Paper page
  147. Silvera, 2017, mTORC1 and −2 coordinate transcriptional and translational reprogramming in resistance to DNA damage and replicative stress in breast cancer cells, Mol. Cell. Biol., 37, 10.1128/MCB.00577-16 · DOI
  148. Fan, 2017, Targeted to mTORC1 drives regression in glioblastoma, Cancer cell, 31, 424, 10.1016/j.ccell.2017.01.014 · DOI · Paper page
  149. Tsuji, 2017, CC-115, a dual inhibitor of mTOR kinase and DNA-PK, blocks DNA damage repair pathways and selectively inhibits ATM-deficient cell growth in vitro, Oncotarget, 8, 74688, 10.18632/oncotarget.20342 · DOI
  150. Gil del Alcazar, 2014, Inhibition of DNA double-strand break repair by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma, Clin. Cancer Res., 20, 1235, 10.1158/1078-0432.CCR-13-1607 · DOI · Paper page
  151. Tsoli, 2018, Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma, Oncotarget, 9, 7541, 10.18632/oncotarget.24045 · DOI
  152. Kaplan, 2014, Strategies for the management of adverse events associated with mTOR inhibitors, Transplant. Rev. (Orlando), 28, 126, 10.1016/j.trre.2014.03.002 · DOI · Paper page
  153. Naing, 2012, Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma, Br. J. Cancer, 107, 1093, 10.1038/bjc.2012.368 · DOI · Paper page
  154. Mateo, 2016, A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies, Br. J. Cancer, 114, 889, 10.1038/bjc.2016.59 · DOI · Paper page
  155. Mahoney, 2018, A small molecule inhibitor of Rheb selectively targets mTORC1 signaling, Nat. Commun., 9, 548, 10.1038/s41467-018-03035-z · DOI · Paper page
  156. Kasznicki, 2014, Metformin in cancer prevention and therapy, Ann. Transl. Med., 2, 57
  157. Chae, 2016, Repurposing metformin for cancer treatment: current clinical studies, Oncotarget, 7, 40767, 10.18632/oncotarget.8194 · DOI · Paper page

Cited by

See all 154

Metadata

Authors
Ma, Y., Vassetzky, Y., & Dokudovskaya, S.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Publisher
Elsevier BV
Published
2018-09
Volume
1865
Issue
9
Pages
1293-1311
ISSN
0167-4889 (ISSN-L)
OpenAlex
W2809388751
Cited by
154
References
76
FWCI
4.32
Type
journal article
Language
en
Open access
bronze
Licence
Funders
  • AFM
  • INSERM
  • LNCC (M27231)
  • ANRS
  • PICS

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: mTORC1 pathway in DNA damage response. https://app.cochat.ai/papers/10.1016/j.bbamcr.2018.06.011
The paper
Ma, Y., Vassetzky, Y., & Dokudovskaya, S. (2018). mTORC1 pathway in DNA damage response. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. https://doi.org/10.1016/j.bbamcr.2018.06.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.